Contact Us
UBC Insights

Insights from
UBC's Expert Voices

Featured Updates

Blog
April 28, 2025 8 min read

Longitudinal Real-World Data: How to Gain Deeper Insights Into Your Clinical Studies
Linking longitudinal real-world data (RWD) to clinical study data offers deeper insights for drug developers. Contextualize study outcomes, extend data collection after the study ends, close the efficacy-effectiveness gap, and identify post-market patterns.
Blog
April 15, 2025 7 min read

Evolving PV Landscape: Artificial Intelligence and Advanced Gene Therapy
UBC Pharmacovigilance experts, Dobrochna Dolicka, Christopher Henry, Alix Garcia and Irene Navarro presented at DIA Europe 2025 on how AI can be used to streamline pharmacovigilance activities and how harmonization of guidelines can be enhanced in order to define a specific framework for gene therapy.
Blog
April 4, 2025 16 min read

Unlocking the Potential of Psychedelic Therapies
Psychedelic-assisted therapies are starting to emerge with potential as treatments for mental health conditions. Explore the evidence behind an increased interest in this use of substances such as psilocybin, MDMA, LSD, and DMT, and the future of research in this area.
Catherine Miller, MSN, CRNP, FNP-BC
Senior Project Manager, Safety, Epidemiology, Registries and Risk Management

Posts by Date

Articles
October 8, 2020 13 min read

Strategies for Virtual and Decentralized Study Designs
UBC"s evidence development experts discuss how the COVID-19 global health crisis is impacting the future of virtual and decentralized studies.
Articles
October 6, 2020 2 min read

UBC Cited in Publication for Smallpox Vaccine Safety Surveillance Study
"Learn more about this prospective study including the enrollment of 20,136 subjects who were active-duty military personnel.
Blog
September 4, 2020 10 min read

The Top 5 Questions to Ask When Developing a REMS
A REMS should be considered when risk mitigation efforts are required beyond product labeling and routine pharmacovigilance.
Blog
August 5, 2020 3 min read

Patient Enrollment Engagement in Indications With Flare-Ups
Recent studies cite that 80% of trials are delayed due to patient recruitment challenges, with up to 20% of enrolled sites never enrolling a single patient.
Blog
July 29, 2020 3 min read

How PV Technology is Enabling Advancements in the Assessment of Patient Safety
Learn how new tools and approaches may significantly streamline and simplify workflows.
Blog
June 22, 2020 3 min read

5 Reasons Why You Need a Pharmacovigilance Partner
Dive into the list curated by UBC's safety and risk management experts.
Blog
June 19, 2020 3 min read

Dr. Annette Stemhagen – DIA 2020 Inspire Award Winner
UBC’s Dr. Annette Stemhagen received well-deserved recognition at the 2020 DIA Global Annual Meeting.
Blog
June 5, 2020 2 min read

Racial Injustice Will Not Be Tolerated
Amid the current health crisis, we are now facing the pain and heartache of the senseless killing of George Floyd.
Blog
June 4, 2020 3 min read

The Essential Role of Real World Evidence Combating COVID-19
Are you prepared for potential accelerated approval requirements?
1 … 9 10 11 12 13 … 15

Press Inquires

Want to know more about us?

Subscribe Now

Want to know more about us?

Subscribe Now

About us

Solutions

Insights

Resources

For HCPs

Clinical

Contact us

About UBC

Other

Evidence Development

Safety & Risk Management

Patient Access

Providers

Technology Solutions

ubc-logo-footer
©2025 United BioSource LLC, all rights reserved
UBC®, CLÆRITY®, SæfetyWorks®, ExpressConnect® and UBC Pathways® are trademarks of United BioSource LLC.
Twitter Linkedin
UBC logo white

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

  • Leverage automation to move fast
  • Always give customers a human to chat to
  • Automate customer support and close leads faster
Return to Homepage
Connect with Us on LinkedIn
UBC logo white

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.